Illumina Body Map 2, young vs old
Gene Symbol | Gene ID | Gene Info |
---|---|---|
TEAD4
|
ENSG00000197905.4 | TEA domain transcription factor 4 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
TEAD4 | hg19_v2_chr12_+_3068466_3068496 | 0.43 | 1.3e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr12_+_86268065 | 2.87 |
ENST00000551529.1
ENST00000256010.6 |
NTS
|
neurotensin |
chr9_+_71944241 | 2.55 |
ENST00000257515.8
|
FAM189A2
|
family with sequence similarity 189, member A2 |
chr10_-_75410771 | 2.52 |
ENST00000372873.4
|
SYNPO2L
|
synaptopodin 2-like |
chr9_-_104249400 | 2.45 |
ENST00000374848.3
|
TMEM246
|
transmembrane protein 246 |
chr14_-_106791536 | 2.30 |
ENST00000390613.2
|
IGHV3-30
|
immunoglobulin heavy variable 3-30 |
chr10_-_4285835 | 2.26 |
ENST00000454470.1
|
LINC00702
|
long intergenic non-protein coding RNA 702 |
chr5_+_53751445 | 2.21 |
ENST00000302005.1
|
HSPB3
|
heat shock 27kDa protein 3 |
chr4_-_110723134 | 2.16 |
ENST00000510800.1
ENST00000512148.1 |
CFI
|
complement factor I |
chr17_-_29624343 | 2.11 |
ENST00000247271.4
|
OMG
|
oligodendrocyte myelin glycoprotein |
chr17_-_66951382 | 1.93 |
ENST00000586539.1
|
ABCA8
|
ATP-binding cassette, sub-family A (ABC1), member 8 |
chr2_-_179672142 | 1.83 |
ENST00000342992.6
ENST00000360870.5 ENST00000460472.2 ENST00000589042.1 ENST00000591111.1 ENST00000342175.6 ENST00000359218.5 |
TTN
|
titin |
chr9_+_13446472 | 1.81 |
ENST00000428006.2
|
RP11-536O18.1
|
RP11-536O18.1 |
chr19_+_35630022 | 1.73 |
ENST00000589209.1
|
FXYD1
|
FXYD domain containing ion transport regulator 1 |
chr14_-_106586656 | 1.71 |
ENST00000390602.2
|
IGHV3-13
|
immunoglobulin heavy variable 3-13 |
chr14_-_106725723 | 1.71 |
ENST00000390609.2
|
IGHV3-23
|
immunoglobulin heavy variable 3-23 |
chr7_-_82073109 | 1.59 |
ENST00000356860.3
|
CACNA2D1
|
calcium channel, voltage-dependent, alpha 2/delta subunit 1 |
chr19_+_35630628 | 1.59 |
ENST00000588715.1
ENST00000588607.1 |
FXYD1
|
FXYD domain containing ion transport regulator 1 |
chr14_-_106518922 | 1.58 |
ENST00000390598.2
|
IGHV3-7
|
immunoglobulin heavy variable 3-7 |
chr16_-_46797149 | 1.56 |
ENST00000536476.1
|
MYLK3
|
myosin light chain kinase 3 |
chr7_-_82073031 | 1.56 |
ENST00000356253.5
ENST00000423588.1 |
CACNA2D1
|
calcium channel, voltage-dependent, alpha 2/delta subunit 1 |
chr4_-_110723335 | 1.54 |
ENST00000394634.2
|
CFI
|
complement factor I |
chr11_+_94439591 | 1.52 |
ENST00000299004.9
|
AMOTL1
|
angiomotin like 1 |
chr2_+_1418154 | 1.51 |
ENST00000423320.1
ENST00000382198.1 |
TPO
|
thyroid peroxidase |
chr2_-_89513402 | 1.51 |
ENST00000498435.1
|
IGKV1-27
|
immunoglobulin kappa variable 1-27 |
chr10_-_4285923 | 1.51 |
ENST00000418372.1
ENST00000608792.1 |
LINC00702
|
long intergenic non-protein coding RNA 702 |
chr17_-_66951474 | 1.48 |
ENST00000269080.2
|
ABCA8
|
ATP-binding cassette, sub-family A (ABC1), member 8 |
chr2_-_151395525 | 1.47 |
ENST00000439275.1
|
RND3
|
Rho family GTPase 3 |
chr15_+_80733570 | 1.45 |
ENST00000533983.1
ENST00000527771.1 ENST00000525103.1 |
ARNT2
|
aryl-hydrocarbon receptor nuclear translocator 2 |
chr1_+_169079823 | 1.45 |
ENST00000367813.3
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide |
chr1_-_79472365 | 1.42 |
ENST00000370742.3
|
ELTD1
|
EGF, latrophilin and seven transmembrane domain containing 1 |
chr2_-_151344172 | 1.40 |
ENST00000375734.2
ENST00000263895.4 ENST00000454202.1 |
RND3
|
Rho family GTPase 3 |
chr19_+_35630344 | 1.38 |
ENST00000455515.2
|
FXYD1
|
FXYD domain containing ion transport regulator 1 |
chr17_+_4855053 | 1.38 |
ENST00000518175.1
|
ENO3
|
enolase 3 (beta, muscle) |
chr16_+_33006369 | 1.37 |
ENST00000425181.3
|
IGHV3OR16-10
|
immunoglobulin heavy variable 3/OR16-10 (non-functional) |
chr4_-_110723194 | 1.37 |
ENST00000394635.3
|
CFI
|
complement factor I |
chr2_+_238767517 | 1.36 |
ENST00000404910.2
|
RAMP1
|
receptor (G protein-coupled) activity modifying protein 1 |
chr17_+_32582293 | 1.36 |
ENST00000580907.1
ENST00000225831.4 |
CCL2
|
chemokine (C-C motif) ligand 2 |
chr1_-_178838404 | 1.33 |
ENST00000444255.1
|
ANGPTL1
|
angiopoietin-like 1 |
chr14_-_106845789 | 1.31 |
ENST00000390617.2
|
IGHV3-35
|
immunoglobulin heavy variable 3-35 (non-functional) |
chr10_+_63808970 | 1.31 |
ENST00000309334.5
|
ARID5B
|
AT rich interactive domain 5B (MRF1-like) |
chr4_+_120056939 | 1.30 |
ENST00000307128.5
|
MYOZ2
|
myozenin 2 |
chr14_-_106622419 | 1.29 |
ENST00000390604.2
|
IGHV3-16
|
immunoglobulin heavy variable 3-16 (non-functional) |
chr3_+_98216448 | 1.29 |
ENST00000427338.1
|
OR5K2
|
olfactory receptor, family 5, subfamily K, member 2 |
chr2_+_239047337 | 1.28 |
ENST00000409223.1
ENST00000305959.4 |
KLHL30
|
kelch-like family member 30 |
chr3_+_123813509 | 1.28 |
ENST00000460856.1
ENST00000240874.3 |
KALRN
|
kalirin, RhoGEF kinase |
chr10_+_123923205 | 1.26 |
ENST00000369004.3
ENST00000260733.3 |
TACC2
|
transforming, acidic coiled-coil containing protein 2 |
chr14_-_106758101 | 1.25 |
ENST00000390611.2
|
IGHV2-26
|
immunoglobulin heavy variable 2-26 |
chr4_+_41614909 | 1.25 |
ENST00000509454.1
ENST00000396595.3 ENST00000381753.4 |
LIMCH1
|
LIM and calponin homology domains 1 |
chr12_-_91572278 | 1.24 |
ENST00000425043.1
ENST00000420120.2 ENST00000441303.2 ENST00000456569.2 |
DCN
|
decorin |
chr7_-_111428957 | 1.24 |
ENST00000417165.1
|
DOCK4
|
dedicator of cytokinesis 4 |
chr13_-_62001982 | 1.23 |
ENST00000409186.1
|
PCDH20
|
protocadherin 20 |
chr2_+_238768187 | 1.23 |
ENST00000254661.4
ENST00000409726.1 |
RAMP1
|
receptor (G protein-coupled) activity modifying protein 1 |
chr6_+_125540951 | 1.22 |
ENST00000524679.1
|
TPD52L1
|
tumor protein D52-like 1 |
chr12_+_101869096 | 1.20 |
ENST00000551346.1
|
SPIC
|
Spi-C transcription factor (Spi-1/PU.1 related) |
chr12_-_91539918 | 1.19 |
ENST00000548218.1
|
DCN
|
decorin |
chr2_+_223916862 | 1.18 |
ENST00000604125.1
|
KCNE4
|
potassium voltage-gated channel, Isk-related family, member 4 |
chr2_-_158184211 | 1.17 |
ENST00000397283.2
|
ERMN
|
ermin, ERM-like protein |
chr10_+_50507232 | 1.15 |
ENST00000374144.3
|
C10orf71
|
chromosome 10 open reading frame 71 |
chr13_-_38172863 | 1.15 |
ENST00000541481.1
ENST00000379743.4 ENST00000379742.4 ENST00000379749.4 ENST00000541179.1 ENST00000379747.4 |
POSTN
|
periostin, osteoblast specific factor |
chr7_-_22234381 | 1.15 |
ENST00000458533.1
|
RAPGEF5
|
Rap guanine nucleotide exchange factor (GEF) 5 |
chrX_-_33146477 | 1.15 |
ENST00000378677.2
|
DMD
|
dystrophin |
chr10_+_50507181 | 1.15 |
ENST00000323868.4
|
C10orf71
|
chromosome 10 open reading frame 71 |
chrX_-_73061339 | 1.14 |
ENST00000602863.1
|
XIST
|
X inactive specific transcript (non-protein coding) |
chr12_-_111358372 | 1.14 |
ENST00000548438.1
ENST00000228841.8 |
MYL2
|
myosin, light chain 2, regulatory, cardiac, slow |
chr4_-_13546632 | 1.14 |
ENST00000382438.5
|
NKX3-2
|
NK3 homeobox 2 |
chr3_-_119379719 | 1.13 |
ENST00000493094.1
|
POPDC2
|
popeye domain containing 2 |
chr3_-_100565249 | 1.13 |
ENST00000495591.1
ENST00000383691.4 ENST00000466947.1 |
ABI3BP
|
ABI family, member 3 (NESH) binding protein |
chr14_-_107049312 | 1.13 |
ENST00000390627.2
|
IGHV3-53
|
immunoglobulin heavy variable 3-53 |
chr3_-_112356944 | 1.12 |
ENST00000461431.1
|
CCDC80
|
coiled-coil domain containing 80 |
chr22_-_42765174 | 1.12 |
ENST00000432473.1
ENST00000412060.1 ENST00000424852.1 |
Z83851.1
|
Z83851.1 |
chr5_-_124081008 | 1.12 |
ENST00000306315.5
|
ZNF608
|
zinc finger protein 608 |
chr3_-_100566492 | 1.11 |
ENST00000528490.1
|
ABI3BP
|
ABI family, member 3 (NESH) binding protein |
chr18_-_3220106 | 1.09 |
ENST00000356443.4
ENST00000400569.3 |
MYOM1
|
myomesin 1 |
chr18_-_3219847 | 1.08 |
ENST00000261606.7
|
MYOM1
|
myomesin 1 |
chr2_+_220299547 | 1.04 |
ENST00000312358.7
|
SPEG
|
SPEG complex locus |
chr8_+_55370487 | 1.04 |
ENST00000297316.4
|
SOX17
|
SRY (sex determining region Y)-box 17 |
chr10_-_61513201 | 1.03 |
ENST00000414264.1
ENST00000594536.1 |
LINC00948
|
long intergenic non-protein coding RNA 948 |
chr3_+_132316081 | 1.02 |
ENST00000249887.2
|
ACKR4
|
atypical chemokine receptor 4 |
chr2_-_188419078 | 1.01 |
ENST00000437725.1
ENST00000409676.1 ENST00000339091.4 ENST00000420747.1 |
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) |
chr4_+_41614720 | 1.00 |
ENST00000509277.1
|
LIMCH1
|
LIM and calponin homology domains 1 |
chr5_-_10308125 | 1.00 |
ENST00000296658.3
|
CMBL
|
carboxymethylenebutenolidase homolog (Pseudomonas) |
chr8_-_70745575 | 0.98 |
ENST00000524945.1
|
SLCO5A1
|
solute carrier organic anion transporter family, member 5A1 |
chr21_-_39870339 | 0.96 |
ENST00000429727.2
ENST00000398905.1 ENST00000398907.1 ENST00000453032.2 ENST00000288319.7 |
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog |
chr15_-_22448819 | 0.95 |
ENST00000604066.1
|
IGHV1OR15-1
|
immunoglobulin heavy variable 1/OR15-1 (non-functional) |
chr4_-_186732048 | 0.95 |
ENST00000448662.2
ENST00000439049.1 ENST00000420158.1 ENST00000431808.1 ENST00000319471.9 |
SORBS2
|
sorbin and SH3 domain containing 2 |
chr20_+_43160458 | 0.92 |
ENST00000372889.1
ENST00000372887.1 ENST00000372882.3 |
PKIG
|
protein kinase (cAMP-dependent, catalytic) inhibitor gamma |
chr3_-_52486841 | 0.92 |
ENST00000496590.1
|
TNNC1
|
troponin C type 1 (slow) |
chr3_-_47932759 | 0.90 |
ENST00000441748.2
ENST00000335271.5 |
MAP4
|
microtubule-associated protein 4 |
chr2_-_211168332 | 0.89 |
ENST00000341685.4
|
MYL1
|
myosin, light chain 1, alkali; skeletal, fast |
chr11_+_12766583 | 0.89 |
ENST00000361985.2
|
TEAD1
|
TEA domain family member 1 (SV40 transcriptional enhancer factor) |
chr5_+_38445641 | 0.89 |
ENST00000397210.3
ENST00000506135.1 ENST00000508131.1 |
EGFLAM
|
EGF-like, fibronectin type III and laminin G domains |
chr11_+_120255997 | 0.88 |
ENST00000532993.1
|
ARHGEF12
|
Rho guanine nucleotide exchange factor (GEF) 12 |
chr6_-_56507586 | 0.88 |
ENST00000439203.1
ENST00000518935.1 ENST00000446842.2 ENST00000370765.6 ENST00000244364.6 |
DST
|
dystonin |
chr2_-_188419200 | 0.87 |
ENST00000233156.3
ENST00000426055.1 ENST00000453013.1 ENST00000417013.1 |
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) |
chr6_+_123317116 | 0.87 |
ENST00000275162.5
|
CLVS2
|
clavesin 2 |
chr1_+_161676739 | 0.86 |
ENST00000236938.6
ENST00000367959.2 ENST00000546024.1 ENST00000540521.1 ENST00000367949.2 ENST00000350710.3 ENST00000540926.1 |
FCRLA
|
Fc receptor-like A |
chr5_+_57878859 | 0.85 |
ENST00000282878.4
|
RAB3C
|
RAB3C, member RAS oncogene family |
chr21_-_27423339 | 0.85 |
ENST00000415997.1
|
APP
|
amyloid beta (A4) precursor protein |
chr11_-_10590238 | 0.84 |
ENST00000256178.3
|
LYVE1
|
lymphatic vessel endothelial hyaluronan receptor 1 |
chr10_-_61513146 | 0.83 |
ENST00000430431.1
|
LINC00948
|
long intergenic non-protein coding RNA 948 |
chrX_-_15402498 | 0.83 |
ENST00000297904.3
|
FIGF
|
c-fos induced growth factor (vascular endothelial growth factor D) |
chr6_-_45983549 | 0.81 |
ENST00000544153.1
|
CLIC5
|
chloride intracellular channel 5 |
chr15_-_20193370 | 0.80 |
ENST00000558565.2
|
IGHV3OR15-7
|
immunoglobulin heavy variable 3/OR15-7 (pseudogene) |
chr8_+_67405438 | 0.76 |
ENST00000305454.3
|
C8orf46
|
chromosome 8 open reading frame 46 |
chr2_+_33683109 | 0.75 |
ENST00000437184.1
|
RASGRP3
|
RAS guanyl releasing protein 3 (calcium and DAG-regulated) |
chr1_+_163038565 | 0.74 |
ENST00000421743.2
|
RGS4
|
regulator of G-protein signaling 4 |
chr5_-_88120151 | 0.74 |
ENST00000506716.1
|
MEF2C
|
myocyte enhancer factor 2C |
chr11_-_10590118 | 0.72 |
ENST00000529598.1
|
LYVE1
|
lymphatic vessel endothelial hyaluronan receptor 1 |
chr7_-_14028488 | 0.70 |
ENST00000405358.4
|
ETV1
|
ets variant 1 |
chr6_-_42690312 | 0.70 |
ENST00000230381.5
|
PRPH2
|
peripherin 2 (retinal degeneration, slow) |
chr1_-_102462565 | 0.69 |
ENST00000370103.4
|
OLFM3
|
olfactomedin 3 |
chr12_+_109554386 | 0.69 |
ENST00000338432.7
|
ACACB
|
acetyl-CoA carboxylase beta |
chr14_-_75530693 | 0.68 |
ENST00000555135.1
ENST00000357971.3 ENST00000553302.1 ENST00000555694.1 ENST00000238618.3 |
ACYP1
|
acylphosphatase 1, erythrocyte (common) type |
chr5_-_41794313 | 0.68 |
ENST00000512084.1
|
OXCT1
|
3-oxoacid CoA transferase 1 |
chr7_-_14029283 | 0.67 |
ENST00000433547.1
ENST00000405192.2 |
ETV1
|
ets variant 1 |
chrX_+_21392873 | 0.67 |
ENST00000379510.3
|
CNKSR2
|
connector enhancer of kinase suppressor of Ras 2 |
chr16_-_2155399 | 0.66 |
ENST00000567946.1
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant) |
chr2_+_201987200 | 0.66 |
ENST00000425030.1
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator |
chr3_+_123813543 | 0.66 |
ENST00000360013.3
|
KALRN
|
kalirin, RhoGEF kinase |
chr7_+_87563557 | 0.65 |
ENST00000439864.1
ENST00000412441.1 ENST00000398201.4 ENST00000265727.7 ENST00000315984.7 ENST00000398209.3 |
ADAM22
|
ADAM metallopeptidase domain 22 |
chr18_+_52258390 | 0.65 |
ENST00000321600.1
|
DYNAP
|
dynactin associated protein |
chrX_+_21392529 | 0.64 |
ENST00000425654.2
ENST00000543067.1 |
CNKSR2
|
connector enhancer of kinase suppressor of Ras 2 |
chr7_+_37960163 | 0.64 |
ENST00000199448.4
ENST00000559325.1 ENST00000423717.1 |
EPDR1
|
ependymin related 1 |
chr4_-_44450814 | 0.64 |
ENST00000360029.3
|
KCTD8
|
potassium channel tetramerization domain containing 8 |
chr10_+_5005445 | 0.61 |
ENST00000380872.4
|
AKR1C1
|
aldo-keto reductase family 1, member C1 |
chr4_-_186682716 | 0.59 |
ENST00000445343.1
|
SORBS2
|
sorbin and SH3 domain containing 2 |
chr6_-_134639235 | 0.58 |
ENST00000533224.1
|
SGK1
|
serum/glucocorticoid regulated kinase 1 |
chr7_+_150811705 | 0.58 |
ENST00000335367.3
|
AGAP3
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 3 |
chr3_+_63428982 | 0.58 |
ENST00000479198.1
ENST00000460711.1 ENST00000465156.1 |
SYNPR
|
synaptoporin |
chr11_+_57308979 | 0.57 |
ENST00000457912.1
|
SMTNL1
|
smoothelin-like 1 |
chr5_-_41794663 | 0.56 |
ENST00000510634.1
|
OXCT1
|
3-oxoacid CoA transferase 1 |
chr17_+_79369249 | 0.55 |
ENST00000574717.2
|
RP11-1055B8.6
|
Uncharacterized protein |
chr2_-_89459813 | 0.54 |
ENST00000390256.2
|
IGKV6-21
|
immunoglobulin kappa variable 6-21 (non-functional) |
chr18_-_66569492 | 0.54 |
ENST00000579678.1
|
RP11-861L17.3
|
Uncharacterized protein |
chr12_+_109569155 | 0.54 |
ENST00000539864.1
|
ACACB
|
acetyl-CoA carboxylase beta |
chr6_-_109330702 | 0.53 |
ENST00000356644.7
|
SESN1
|
sestrin 1 |
chr1_-_60392452 | 0.53 |
ENST00000371204.3
|
CYP2J2
|
cytochrome P450, family 2, subfamily J, polypeptide 2 |
chr5_-_88120083 | 0.53 |
ENST00000509373.1
|
MEF2C
|
myocyte enhancer factor 2C |
chr3_-_164875850 | 0.52 |
ENST00000472120.1
|
RP11-747D18.1
|
RP11-747D18.1 |
chr4_+_141264597 | 0.52 |
ENST00000338517.4
ENST00000394203.3 ENST00000506322.1 |
SCOC
|
short coiled-coil protein |
chr8_-_30002179 | 0.51 |
ENST00000320542.3
|
MBOAT4
|
membrane bound O-acyltransferase domain containing 4 |
chr8_+_22225041 | 0.51 |
ENST00000289952.5
ENST00000524285.1 |
SLC39A14
|
solute carrier family 39 (zinc transporter), member 14 |
chr6_-_45983581 | 0.51 |
ENST00000339561.6
|
CLIC5
|
chloride intracellular channel 5 |
chr1_+_161676983 | 0.51 |
ENST00000367957.2
|
FCRLA
|
Fc receptor-like A |
chr8_-_27115931 | 0.50 |
ENST00000523048.1
|
STMN4
|
stathmin-like 4 |
chr3_+_130279178 | 0.50 |
ENST00000358511.6
ENST00000453409.2 |
COL6A6
|
collagen, type VI, alpha 6 |
chr2_-_180610767 | 0.50 |
ENST00000409343.1
|
ZNF385B
|
zinc finger protein 385B |
chr1_+_178310581 | 0.50 |
ENST00000462775.1
|
RASAL2
|
RAS protein activator like 2 |
chr2_-_119605253 | 0.50 |
ENST00000295206.6
|
EN1
|
engrailed homeobox 1 |
chr1_+_164528616 | 0.49 |
ENST00000340699.3
|
PBX1
|
pre-B-cell leukemia homeobox 1 |
chr1_+_66458072 | 0.49 |
ENST00000423207.2
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific |
chr11_+_60223225 | 0.48 |
ENST00000524807.1
ENST00000345732.4 |
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1 |
chr11_-_6440624 | 0.47 |
ENST00000311051.3
|
APBB1
|
amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) |
chr3_+_101546827 | 0.46 |
ENST00000461724.1
ENST00000483180.1 ENST00000394054.2 |
NFKBIZ
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta |
chr6_+_31638156 | 0.46 |
ENST00000409525.1
|
LY6G5B
|
lymphocyte antigen 6 complex, locus G5B |
chrX_-_10588595 | 0.46 |
ENST00000423614.1
ENST00000317552.4 |
MID1
|
midline 1 (Opitz/BBB syndrome) |
chr3_-_142608001 | 0.46 |
ENST00000295992.3
|
PCOLCE2
|
procollagen C-endopeptidase enhancer 2 |
chr19_+_37825526 | 0.45 |
ENST00000592768.1
ENST00000591417.1 ENST00000585623.1 ENST00000592168.1 ENST00000591391.1 ENST00000392153.3 ENST00000589392.1 ENST00000324411.4 |
HKR1
|
HKR1, GLI-Kruppel zinc finger family member |
chr15_-_65398647 | 0.45 |
ENST00000502113.2
|
UBAP1L
|
ubiquitin associated protein 1-like |
chr19_+_37837185 | 0.44 |
ENST00000541583.2
|
HKR1
|
HKR1, GLI-Kruppel zinc finger family member |
chr11_-_101778665 | 0.44 |
ENST00000534527.1
|
ANGPTL5
|
angiopoietin-like 5 |
chr2_+_90060377 | 0.44 |
ENST00000436451.2
|
IGKV6D-21
|
immunoglobulin kappa variable 6D-21 (non-functional) |
chr11_-_71639446 | 0.44 |
ENST00000534704.1
|
RP11-849H4.2
|
Putative short transient receptor potential channel 2-like protein |
chr8_-_134511587 | 0.43 |
ENST00000523855.1
ENST00000523854.1 |
ST3GAL1
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
chr15_+_89164560 | 0.43 |
ENST00000379231.3
ENST00000559528.1 |
AEN
|
apoptosis enhancing nuclease |
chr2_-_237150258 | 0.43 |
ENST00000330842.6
|
ASB18
|
ankyrin repeat and SOCS box containing 18 |
chr4_+_70861647 | 0.43 |
ENST00000246895.4
ENST00000381060.2 |
STATH
|
statherin |
chr12_-_125401885 | 0.42 |
ENST00000542416.1
|
UBC
|
ubiquitin C |
chr11_-_102595681 | 0.42 |
ENST00000236826.3
|
MMP8
|
matrix metallopeptidase 8 (neutrophil collagenase) |
chr10_+_24528108 | 0.42 |
ENST00000438429.1
|
KIAA1217
|
KIAA1217 |
chr3_-_196987309 | 0.41 |
ENST00000453607.1
|
DLG1
|
discs, large homolog 1 (Drosophila) |
chr18_+_3466248 | 0.41 |
ENST00000581029.1
ENST00000581442.1 ENST00000579007.1 |
RP11-838N2.4
|
RP11-838N2.4 |
chr8_+_67405755 | 0.40 |
ENST00000521495.1
|
C8orf46
|
chromosome 8 open reading frame 46 |
chr4_-_39033963 | 0.40 |
ENST00000381938.3
|
TMEM156
|
transmembrane protein 156 |
chr2_-_231989808 | 0.40 |
ENST00000258400.3
|
HTR2B
|
5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled |
chr5_+_154092396 | 0.39 |
ENST00000336314.4
|
LARP1
|
La ribonucleoprotein domain family, member 1 |
chr4_+_40337340 | 0.39 |
ENST00000310169.2
|
CHRNA9
|
cholinergic receptor, nicotinic, alpha 9 (neuronal) |
chr21_-_33975547 | 0.39 |
ENST00000431599.1
|
C21orf59
|
chromosome 21 open reading frame 59 |
chr2_-_161056802 | 0.39 |
ENST00000283249.2
ENST00000409872.1 |
ITGB6
|
integrin, beta 6 |
chr15_-_42343388 | 0.37 |
ENST00000399518.3
|
PLA2G4E
|
phospholipase A2, group IVE |
chr7_+_80267973 | 0.37 |
ENST00000394788.3
ENST00000447544.2 |
CD36
|
CD36 molecule (thrombospondin receptor) |
chr1_-_151798546 | 0.37 |
ENST00000356728.6
|
RORC
|
RAR-related orphan receptor C |
chr2_-_136875712 | 0.37 |
ENST00000241393.3
|
CXCR4
|
chemokine (C-X-C motif) receptor 4 |
chr7_-_45956856 | 0.37 |
ENST00000428530.1
|
IGFBP3
|
insulin-like growth factor binding protein 3 |
chr12_-_123011476 | 0.37 |
ENST00000528279.1
ENST00000344591.4 ENST00000526560.2 |
RSRC2
|
arginine/serine-rich coiled-coil 2 |
chr12_-_123011536 | 0.36 |
ENST00000331738.7
ENST00000354654.2 |
RSRC2
|
arginine/serine-rich coiled-coil 2 |
chr4_+_87928413 | 0.36 |
ENST00000544085.1
|
AFF1
|
AF4/FMR2 family, member 1 |
chr6_-_134638767 | 0.35 |
ENST00000524929.1
|
SGK1
|
serum/glucocorticoid regulated kinase 1 |
chr2_-_44550441 | 0.35 |
ENST00000420756.1
ENST00000444696.1 |
PREPL
|
prolyl endopeptidase-like |
chr8_-_27115903 | 0.34 |
ENST00000350889.4
ENST00000519997.1 ENST00000519614.1 ENST00000522908.1 ENST00000265770.7 |
STMN4
|
stathmin-like 4 |
chr1_+_164529004 | 0.34 |
ENST00000559240.1
ENST00000367897.1 ENST00000540236.1 ENST00000401534.1 |
PBX1
|
pre-B-cell leukemia homeobox 1 |
chr11_-_71639613 | 0.34 |
ENST00000528184.1
ENST00000528511.2 |
RP11-849H4.2
|
Putative short transient receptor potential channel 2-like protein |
chrX_+_21392553 | 0.34 |
ENST00000279451.4
|
CNKSR2
|
connector enhancer of kinase suppressor of Ras 2 |
chr12_-_76478446 | 0.34 |
ENST00000393263.3
ENST00000548044.1 ENST00000547704.1 ENST00000431879.3 ENST00000549596.1 ENST00000550934.1 ENST00000551600.1 ENST00000547479.1 ENST00000547773.1 ENST00000544816.1 ENST00000542344.1 ENST00000548273.1 |
NAP1L1
|
nucleosome assembly protein 1-like 1 |
chr12_-_49393092 | 0.34 |
ENST00000421952.2
|
DDN
|
dendrin |
chr21_+_17214724 | 0.33 |
ENST00000449491.1
|
USP25
|
ubiquitin specific peptidase 25 |
chr15_-_72563585 | 0.33 |
ENST00000287196.9
ENST00000260376.7 |
PARP6
|
poly (ADP-ribose) polymerase family, member 6 |
chr4_+_55096010 | 0.32 |
ENST00000503856.1
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide |
chr11_+_60223312 | 0.32 |
ENST00000532491.1
ENST00000532073.1 ENST00000534668.1 ENST00000528313.1 ENST00000533306.1 |
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1 |
chr16_+_30386098 | 0.32 |
ENST00000322861.7
|
MYLPF
|
myosin light chain, phosphorylatable, fast skeletal muscle |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 4.7 | GO:0010732 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
0.5 | 1.5 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.5 | 1.4 | GO:2000502 | negative regulation of natural killer cell chemotaxis(GO:2000502) |
0.4 | 3.4 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.4 | 3.1 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
0.3 | 1.0 | GO:0061010 | endodermal cell fate determination(GO:0007493) regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) gall bladder development(GO:0061010) |
0.3 | 2.6 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.2 | 1.9 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.2 | 0.9 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.2 | 3.6 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.2 | 2.2 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.2 | 1.4 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) positive regulation of calcium:sodium antiporter activity(GO:1903281) |
0.2 | 1.2 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
0.2 | 1.1 | GO:1990523 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) bone regeneration(GO:1990523) |
0.2 | 1.3 | GO:0003172 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
0.2 | 0.5 | GO:1902173 | negative regulation of keratinocyte apoptotic process(GO:1902173) |
0.2 | 0.8 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
0.2 | 0.7 | GO:0072287 | metanephric distal tubule morphogenesis(GO:0072287) |
0.2 | 2.4 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.2 | 0.5 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
0.2 | 1.2 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.2 | 1.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 1.1 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.1 | 1.0 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.1 | 0.9 | GO:0051012 | microtubule sliding(GO:0051012) |
0.1 | 0.5 | GO:0061743 | motor learning(GO:0061743) |
0.1 | 20.3 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 0.5 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.1 | 1.1 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.1 | 0.6 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.1 | 0.4 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
0.1 | 0.6 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
0.1 | 2.9 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 1.3 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 0.2 | GO:1900737 | regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
0.1 | 1.3 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.1 | 0.3 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 0.4 | GO:0072752 | cellular response to rapamycin(GO:0072752) |
0.1 | 0.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.5 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 0.4 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.1 | 0.7 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.1 | 0.9 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 0.7 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.1 | 0.4 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.1 | 1.6 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.1 | 0.6 | GO:0070543 | response to linoleic acid(GO:0070543) blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
0.0 | 0.2 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
0.0 | 0.4 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.0 | 1.4 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.0 | 0.3 | GO:1900827 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.0 | 0.3 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.0 | 0.5 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
0.0 | 0.9 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.0 | 0.7 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.0 | 0.4 | GO:1903764 | regulation of potassium ion export across plasma membrane(GO:1903764) |
0.0 | 0.2 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
0.0 | 0.7 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.0 | 0.7 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.0 | 0.3 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.0 | 1.8 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 0.3 | GO:0015793 | glycerol transport(GO:0015793) |
0.0 | 0.3 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.0 | 0.5 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.0 | 0.2 | GO:0070352 | positive regulation of white fat cell proliferation(GO:0070352) |
0.0 | 0.7 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.0 | 0.4 | GO:0046541 | saliva secretion(GO:0046541) |
0.0 | 1.4 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.0 | 0.2 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.0 | 0.5 | GO:1903874 | ferrous iron transport(GO:0015684) ferrous iron transmembrane transport(GO:1903874) |
0.0 | 0.7 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.0 | 1.9 | GO:0060612 | adipose tissue development(GO:0060612) |
0.0 | 2.5 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.0 | 0.9 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.0 | 2.3 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.0 | 0.1 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
0.0 | 0.7 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 0.2 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.0 | 0.4 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.0 | 0.1 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
0.0 | 0.7 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.2 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.0 | 0.3 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.0 | 0.5 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.0 | 0.3 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 0.3 | GO:0090292 | nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.0 | 0.4 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
0.0 | 1.1 | GO:0030239 | myofibril assembly(GO:0030239) |
0.0 | 0.5 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.7 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.8 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.0 | 0.3 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.9 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.0 | 1.2 | GO:0001824 | blastocyst development(GO:0001824) |
0.0 | 2.3 | GO:0031032 | actomyosin structure organization(GO:0031032) |
0.0 | 0.0 | GO:0032827 | negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) positive regulation of cytolysis in other organism(GO:0051714) |
0.0 | 0.1 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
0.0 | 0.2 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.0 | 0.7 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.0 | 0.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 2.2 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.4 | 2.6 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.2 | 6.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.2 | 0.5 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
0.2 | 3.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.2 | 2.4 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.2 | 8.7 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.2 | 0.9 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.2 | 1.4 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.9 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.1 | 0.9 | GO:0031673 | H zone(GO:0031673) |
0.1 | 4.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.7 | GO:0002133 | polycystin complex(GO:0002133) |
0.1 | 1.3 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.1 | 0.3 | GO:0097679 | other organism cytoplasm(GO:0097679) |
0.1 | 1.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 1.2 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 0.2 | GO:0039713 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
0.1 | 3.0 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.1 | 0.7 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.0 | 0.5 | GO:0016013 | syntrophin complex(GO:0016013) |
0.0 | 0.3 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.0 | 0.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 1.0 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.5 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.0 | 0.7 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) ripoptosome(GO:0097342) |
0.0 | 0.2 | GO:0035976 | AP1 complex(GO:0035976) |
0.0 | 0.2 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.0 | 0.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 6.4 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.4 | GO:0097025 | lateral loop(GO:0043219) MPP7-DLG1-LIN7 complex(GO:0097025) |
0.0 | 0.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.6 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.4 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.6 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.0 | 0.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 1.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 1.4 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.3 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.0 | 0.3 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.0 | 1.1 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.7 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 0.6 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 3.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 1.3 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 2.7 | GO:0043679 | axon terminus(GO:0043679) |
0.0 | 0.1 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.0 | 0.5 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.0 | 1.0 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 0.3 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 1.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 4.1 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.0 | 0.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.1 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 3.1 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
0.6 | 2.6 | GO:0031716 | calcitonin receptor activity(GO:0004948) calcitonin receptor binding(GO:0031716) |
0.3 | 1.2 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.3 | 3.6 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.3 | 1.4 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.2 | 0.7 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
0.2 | 1.3 | GO:0051373 | FATZ binding(GO:0051373) |
0.2 | 1.5 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
0.2 | 1.2 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
0.2 | 1.8 | GO:0031433 | telethonin binding(GO:0031433) |
0.2 | 1.6 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.2 | 1.4 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.6 | GO:0005018 | platelet-derived growth factor alpha-receptor activity(GO:0005018) |
0.1 | 0.4 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 8.7 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.6 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) indanol dehydrogenase activity(GO:0047718) |
0.1 | 0.7 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.1 | 0.5 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.9 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 0.3 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
0.1 | 2.2 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 1.5 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.5 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 2.9 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 1.4 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 5.8 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.2 | GO:0052590 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.1 | 0.8 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 1.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 1.1 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 5.9 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 1.3 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 1.1 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.3 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.1 | 0.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 1.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 2.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 8.9 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.2 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.0 | 0.3 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.0 | 0.5 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.0 | 0.2 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.0 | 0.1 | GO:0016263 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity(GO:0016263) |
0.0 | 1.6 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 5.1 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.4 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.9 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.0 | 1.1 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.4 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 0.3 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.9 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 0.4 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.0 | 1.3 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.3 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.0 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.8 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.4 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.0 | 0.4 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 0.5 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.9 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.2 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.7 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 0.4 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.4 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.0 | 0.1 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.0 | 1.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 2.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.8 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 1.2 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.7 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.6 | GO:0030552 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) cAMP binding(GO:0030552) |
0.0 | 0.2 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.4 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.0 | 0.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.1 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 4.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 1.9 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 2.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 2.8 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 2.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 1.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 3.0 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.7 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 1.1 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 5.1 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 1.6 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 2.4 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.4 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 3.4 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 4.1 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 1.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.8 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 1.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 5.6 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 1.4 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 1.2 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 1.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.4 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.5 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 1.0 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 0.5 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 1.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 1.1 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 0.4 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.3 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 2.4 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.7 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.2 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 1.2 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |